Yu K, Shin Y, Kim D, Kim J, Kang J, Singh P
Virol J. 2025; 22(1):65.
PMID: 40055750
PMC: 11887385.
DOI: 10.1186/s12985-025-02680-3.
Shin Y, Park C, Kim D, Kim S, Lee S, Lee J
Antimicrob Agents Chemother. 2024; 68(10):e0064324.
PMID: 39230310
PMC: 11459959.
DOI: 10.1128/aac.00643-24.
Carmi O, Gotlieb Y, Shemer-Avni Y, Bentwich Z
Microorganisms. 2024; 12(3).
PMID: 38543476
PMC: 10971904.
DOI: 10.3390/microorganisms12030425.
Lian Y, Huang Z, Liu X, Deng Z, Gao D, Wang X
Curr HIV Res. 2024; 22(2):82-90.
PMID: 38532605
DOI: 10.2174/011570162X301289240320082840.
Yang Q, Barbachano-Guerrero A, Fairchild L, Rowland T, Dowell R, Allen M
J Virol. 2024; 98(3):e0156323.
PMID: 38323811
PMC: 10949493.
DOI: 10.1128/jvi.01563-23.
HIV Preintegration Transcription and Host Antagonism.
Wu Y
Curr HIV Res. 2023; 21(3):160-171.
PMID: 37345240
PMC: 10661980.
DOI: 10.2174/1570162X21666230621122637.
HECT domain interaction with ubiquitin binding sites on Tsg101-UEV controls HIV-1 egress, maturation, and infectivity.
Nyenhuis D, Rajasekaran R, Watanabe S, Strub M, Khan M, Powell M
J Biol Chem. 2023; 299(2):102901.
PMID: 36642186
PMC: 9944984.
DOI: 10.1016/j.jbc.2023.102901.
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro.
Kong L, Shata M, Brown J, Lyons M, Sherman K, Blackard J
J Neurovirol. 2022; 28(4-6):583-594.
PMID: 35976538
PMC: 11135282.
DOI: 10.1007/s13365-022-01090-3.
A functional map of HIV-host interactions in primary human T cells.
Hiatt J, Hultquist J, McGregor M, Bouhaddou M, Leenay R, Simons L
Nat Commun. 2022; 13(1):1752.
PMID: 35365639
PMC: 8976027.
DOI: 10.1038/s41467-022-29346-w.
Engineering T-Cell Resistance to HIV-1 Infection via Knock-In of Peptides from the Heptad Repeat 2 Domain of gp41.
Maslennikova A, Kruglova N, Kalinichenko S, Komkov D, Shepelev M, Golubev D
mBio. 2022; 13(1):e0358921.
PMID: 35073736
PMC: 8787484.
DOI: 10.1128/mbio.03589-21.
Fabrication and Biological Activities of Plasmid DNA Gene Carrier Nanoparticles Based on Biodegradable l-Tyrosine Polyurethane.
Park S, Yun Y, Park B, Seo H, Chung I
Pharmaceuticals (Basel). 2022; 15(1).
PMID: 35056074
PMC: 8780858.
DOI: 10.3390/ph15010017.
Antiviral Activity and Resistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor JTP-0157602.
Ohata Y, Tomonaga M, Watanabe Y, Tomura K, Kimura K, Akaki T
J Virol. 2022; 96(6):e0184321.
PMID: 35045265
PMC: 8941924.
DOI: 10.1128/JVI.01843-21.
Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
Nguyen K, Dobrowolski C, Shukla M, Cho W, Luttge B, Karn J
PLoS Pathog. 2021; 17(10):e1010014.
PMID: 34673825
PMC: 8562785.
DOI: 10.1371/journal.ppat.1010014.
Extracellular Microvesicles Released From Brain Endothelial Cells are Detected in Animal Models Of HIV-1 Signifying Unresolved Inflammation.
Ramirez S, Buzhdygan T, Hale J, Cheng L, Li G, Hoover-Hankerson B
J Neuroimmune Pharmacol. 2021; 16(4):785-795.
PMID: 34435263
PMC: 8714626.
DOI: 10.1007/s11481-021-10008-5.
Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip.
Koma T, Yokoyama M, Kotani O, Doi N, Nakanishi N, Okubo H
J Virol. 2021; 95(13):e0217720.
PMID: 33883222
PMC: 8315996.
DOI: 10.1128/JVI.02177-20.
The role of pseudotype neutralization assays in understanding SARS CoV-2.
Cantoni D, Mayora-Neto M, Temperton N
Oxf Open Immunol. 2021; 2(1):iqab005.
PMID: 33738456
PMC: 7928640.
DOI: 10.1093/oxfimm/iqab005.
Experimental Systems for Measuring HIV Latency and Reactivation.
Fujinaga K, Cary D
Viruses. 2020; 12(11).
PMID: 33182414
PMC: 7696534.
DOI: 10.3390/v12111279.
Cell Cultures for Virology: Usability, Advantages, and Prospects.
Dolskiy A, Grishchenko I, Yudkin D
Int J Mol Sci. 2020; 21(21).
PMID: 33121109
PMC: 7662242.
DOI: 10.3390/ijms21217978.
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.
Ndashimye E, Avino M, Olabode A, Poon A, Gibson R, Li Y
J Antimicrob Chemother. 2020; 75(12):3525-3533.
PMID: 32853364
PMC: 7662175.
DOI: 10.1093/jac/dkaa355.
HSF1 Activation Can Restrict HIV Replication.
Nekongo E, Ponomarenko A, Dewal M, Butty V, Browne E, Shoulders M
ACS Infect Dis. 2020; 6(7):1659-1666.
PMID: 32502335
PMC: 7434488.
DOI: 10.1021/acsinfecdis.0c00166.